|
|
| (11 intermediate revisions by 4 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{Adrenal insufficiency}} | | {{Secondary adrenal insufficiency}} |
| {{CMG}} | | {{CMG}} {{AE}} {{ADS}} |
| | |
| {{PleaseHelp}} | |
|
| |
|
| ==Overview== | | ==Overview== |
| | There is insufficient evidence to recommend routine screening for secondary adrenal insufficiency. |
|
| |
|
| ==Screening== | | ==Screening== |
| | | There is insufficient evidence to recommend routine screening for secondary adrenal insufficiency. |
| Although screening for Addison disease in the traditional sense is not routinely done, there are laboratory tests that can be undertaken if a diagnosis for Addison is suspected. For example, these include:
| |
| | |
| • Blood testing; measuring blood levels of sodium, potassium, cortisol and ACTH. A blood test can also measure antibodies associated with the condition.
| |
| | |
| • ACTH stimulation test; this test involves measuring the level of cortisol in the blood before and after an injection of synthetic ACTH.
| |
| | |
| • Insulin-induced hypoglycemia test; occasionally, this test is performed if pituitary disease is a possible cause of adrenal insufficiency (secondary adrenal insufficiency).
| |
|
| |
| • Imaging tests; a computerized tomography (CT) scan of the abdomen to check the size of the adrenal glands and look for other abnormalities that may give insight to the cause of the adrenal insufficiency. An MRI scan of the pituitary gland may also be indicated.
| |
| | |
| It is important to note that some papers have found that adolescents with diabetes type 1 who experience recurrent unexplained hypoglycemia should be screened for Addison’s disease. [13] [14]
| |
|
| |
|
| ==References== | | ==References== |
| Line 30: |
Line 18: |
| [[Category:Needs content]] | | [[Category:Needs content]] |
| [[Category:Needs overview]] | | [[Category:Needs overview]] |
|
| |
| 1. Rogoff JM, Stewart GN. THE INFLUENCE OF ADRENAL EXTRACTS ON THE SURVIVAL PERIOD OF ADRENALECTOMIZED DOGS. Science. 1927 Oct 7;66(1710):327–328. [PubMed]
| |
|
| |
| 2. Betterle C, Morlin L. Autoimmune Addison’s disease. In: Ghizzoni L, Cappa M, Chrousos G, Loche S, Maghnie M, eds. Pediatric Adrenal Diseases. Endocrine Development. Vol. 20. Padova, Italy: Karger Publishers; 2011: 161–172.
| |
|
| |
| 3. Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatment. Current Opinion in Endocrinology, Diabetes and Obesity. 2010;(3):217–223
| |
|
| |
| 4. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003 May 31. 361(9372):1881-93. [Medline].
| |
|
| |
| 5. Besser GM, Thorner MO. Adrenal insufficiency. Clinical Endocrinology. St Louis, Mo: Mosby-Year Book; 1996. [CD-ROM]
| |
|
| |
| 6. Purandare A, Godil MA, Prakash D, Parker R, Zerah M, Wilson TA. Spontaneous adrenal hemorrhage associated with transient antiphospholipid antibody in a child. Clin Pediatr (Phila). 2001 Jun. 40(6):347-50. [Medline].
| |
|
| |
| 7. Olafsson AS, Sigurjonsdottir HA. INCREASING PREVALENCE OF ADDISON DISEASE: RESULTS FROM A NATIONWIDE STUDY. Endocr Pract. 2016 Jan. 22 (1):30-5. [Medline].
| |
|
| |
| 8. Kyriazopoulou V. Glucocorticoid replacement therapy in patients with Addison's disease. Expert Opin Pharmacother. 2007 Apr. 8(6):725-9. [Medline].
| |
|
| |
| 9. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, et al. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006 Dec. 91(12):4849-53. [Medline]. [Full Text]
| |